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Background: In a primary prevention setting, serum markers of lipid metabolism (low density lipoprotein or LDL) & inflammation (C-reactive 
protein or CRP) predict risk of future coronary events. JUPITER trial demonstrated increased risk in subjects with elevated CRP, even with normal 
LDL. Both LDL & CRP are associated with anatomic subclinical disease, i.e. coronary artery calcification (CAC). We sought to understand the relative 
strength of this association.
Methods: Out of 1900 consecutive nondiabetic patients that underwent non contrast ECG-gated CAC scoring, we identified 2 subgroups: Group A 
(182 subjects with CRP<2 mg/l & LDL≥130 mg/dl) & group B (154 subjects that met JUPITER trial criteria: LDL<130 mg/dl & CRP≥2 mg/l). Total 
Agatston score was recorded & patients were divided into following categories: No CAC, mild (CAC 1-100), moderate (CAC 101-400) & severe (> 
400). CAC percentiles were derived from multiethnic study of subclinical atherosclerosis & divided into quartiles. Clinical data was recorded.
Results: The data of the 2 groups is shown in Figure. In both groups, > 40 % subjects had no CAC or had low CAC percentile score. Only 6-7% 
subjects in both groups had Agatston score > 400.
Conclusions: In primary prevention, a high (& similar) proportion of subjects (those meeting JUPITER criteria & those with normal CRP but 
high LDL) have no CAC. CAC might aid in further risk-stratification & identification of a lower-risk subgroup with metabolic derangements where 
prophylactic statins may not be needed.
 
